{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:24:48Z","timestamp":1789010688585,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jhep.2016.10.025","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T04:47:53Z","timestamp":1477716473000},"page":"442-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?"],"prefix":"10.1016","volume":"66","author":[{"given":"Jonel","family":"Trebicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.10.025_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0010","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.12703\/P6-95","article-title":"Future therapy of portal hypertension in liver cirrhosis \u2013 a guess","volume":"6","author":"Sauerbruch","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.jhep.2016.10.025_b0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.27117","article-title":"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis","volume":"60","author":"Granzow","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0025","article-title":"Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis","author":"Klein","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","article-title":"Recent advances in our understanding of hepatorenal syndrome","volume":"9","author":"Wong","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0040","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MEG.0b013e32834a75dc","article-title":"Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt","volume":"23","author":"Trebicka","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0045","doi-asserted-by":"crossref","first-page":"e83341","DOI":"10.1371\/journal.pone.0083341","article-title":"Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension","volume":"8","author":"Trebicka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.10.025_b0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0055","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.V1081833","article-title":"Hepatorenal syndrome","volume":"10","author":"Gines","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2016.10.025_b0060","doi-asserted-by":"crossref","first-page":"e1681","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.10.025_b0065","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/hep.26314","article-title":"Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy","volume":"57","author":"Laleman","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(80)90063-X","article-title":"Propranolol\u2013a medical treatment for portal hypertension?","volume":"2","author":"Lebrec","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.10.025_b0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hep.1840020502","article-title":"The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study","volume":"2","author":"Lebrec","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0090","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0095","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0100","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs. hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.10.025_b0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","article-title":"TIPS: 25 years later","volume":"59","author":"Rossle","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/liv.12613","article-title":"Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension","volume":"35","author":"Trebicka","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.10.025_b0120","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2016.01.022","article-title":"Assessment of response to beta-blockers by expression of betaArr2 and RhoA\/ROCK2 in antrum mucosa in cirrhotic patients","volume":"64","author":"Trebicka","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0125","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/003655202320378284","article-title":"Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt","volume":"37","author":"Brensing","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.10.025_b0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to beta-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts vs. large-volume paracentesis in cirrhosis: a matched cohort analysis","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2016.10.025_b0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2014.09.032","article-title":"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"62","author":"Berres","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/liv.12922","article-title":"Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt","volume":"36","author":"Berres","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.10.025_b0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jgh.12725","article-title":"Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion","volume":"30","author":"Tan","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0160","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1148\/radiol.2016151625","article-title":"Early liver failure after transjugular intrahepatic portosystemic shunt in patients with cirrhosis with model for end-stage liver disease score of 12 or less: incidence, outcome, and prognostic factors","volume":"280","author":"Luca","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2016.10.025_b0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.diii.2016.02.004","article-title":"The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement","volume":"97","author":"Borentain","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jhep.2016.10.025_b0170","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.27438","article-title":"Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding","volume":"61","author":"Wu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0175","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/apt.13569","article-title":"Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt","volume":"43","author":"Wannhoff","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2016.10.025_b0180","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.10.025_b0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study","volume":"58","author":"Garcia-Pagan","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0195","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2011.05.013","article-title":"Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool?","volume":"55","author":"Thabut","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0200","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/apt.12934","article-title":"Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival","volume":"40","author":"Rudler","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2016.10.025_b0205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MEG.0000000000000403","article-title":"Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials","volume":"27","author":"Deltenre","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0210","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gut.2008.171207","article-title":"Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial","volume":"58","author":"Garcia-Pagan","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cgh.2012.02.011","article-title":"Patients whose first episode of bleeding occurs while taking a beta-blocker have high long-term risks of rebleeding and death","volume":"10","author":"de Souza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0220","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.1840360611","article-title":"\u201cA La Carte\u201d treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding","volume":"36","author":"Bureau","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0225","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt vs. endoscopic therapy + beta-blocker for prevention of variceal rebleeding","volume":"63","author":"Holster","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM199401203300303","article-title":"The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding","volume":"330","author":"Rossle","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.10.025_b0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial","volume":"53","author":"Riggio","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0240","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.10.025_b0245","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.10.025_b0250","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.crad.2015.02.002","article-title":"Survival benefit of TIPS vs. serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis","volume":"70","author":"Gaba","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jhep.2016.10.025_b0255","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0260","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/gut.52.6.879","article-title":"Child-Pugh vs. MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt","volume":"52","author":"Angermayr","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0265","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2016.10.025_b0270","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-8278(01)00309-9","article-title":"MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt","volume":"36","author":"Salerno","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0275","first-page":"5211","article-title":"Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis","volume":"18","author":"Heinzow","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.10.025_b0280","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2010.08.025","article-title":"Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS","volume":"54","author":"Bureau","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0285","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26684","article-title":"Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests","volume":"59","author":"Berlioux","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0290","doi-asserted-by":"crossref","first-page":"e1701","DOI":"10.1053\/j.gastro.2009.08.003","article-title":"Hepatic encephalopathy and fitness to drive","volume":"137","author":"Kircheis","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.10.025_b0295","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.27369","article-title":"Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients","volume":"61","author":"Anadol","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0305","doi-asserted-by":"crossref","first-page":"e103779","DOI":"10.1371\/journal.pone.0103779","article-title":"The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS","volume":"9","author":"Jansen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.10.025_b0310","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-015-3783-9","article-title":"Circulating elastin fragments are not affected by hepatic, renal and hemodynamic changes, but reflect survival in cirrhosis with TIPS","author":"Nielsen","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2016.10.025_b0315","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.10.025_b0320","article-title":"Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis","author":"Hackstein","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0325","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.RVI.0000240651.38289.4B","article-title":"Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites","volume":"17","author":"Harrod-Kim","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2016.10.025_b0330","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jvir.2014.10.021","article-title":"Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents","volume":"26","author":"Pieper","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2016.10.025_b0335","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jvir.2007.05.009","article-title":"Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study","volume":"18","author":"Maleux","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2016.10.025_b0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000288522","article-title":"Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt","volume":"83","author":"Biecker","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2016.10.025_b0345","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2361040530","article-title":"Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding","volume":"236","author":"Tesdal","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2016.10.025_b0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.51.2.270","article-title":"The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations","volume":"51","author":"Tripathi","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0355","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.10.025_b0360","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bpg.2013.06.012","article-title":"Liver in haematological disorders","volume":"27","author":"Pieri","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2016.10.025_b0365","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.transproceed.2012.09.050","article-title":"Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation","volume":"44","author":"D'Avola","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2016.10.025_b0370","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.10.025_b0375","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.10.025_b0380","doi-asserted-by":"crossref","first-page":"e1251","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.10.025_b0385","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.10.025_b0390","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10620-011-1975-5","article-title":"Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients","volume":"57","author":"Qi","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2016.10.025_b0395","first-page":"5","volume":"5","author":"Bureau","year":"2016","journal-title":"Gastroenterology."}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816306195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816306195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T19:51:41Z","timestamp":1657569101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816306195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0168827816306195"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.10.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}